<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<STUDY_SET>
    <STUDY alias="DRP007734" center_name="UT_IMS" accession="DRP007734">
        <IDENTIFIERS>
            <PRIMARY_ID label="BioProject ID">PRJDB12362</PRIMARY_ID>
        </IDENTIFIERS>
        <DESCRIPTOR>
            <STUDY_TITLE>Reversion to quiescence preserves hematopoietic stem cells following genome editing</STUDY_TITLE>
            <STUDY_TYPE existing_study_type="Other"/>
            <STUDY_ABSTRACT>Other than genetically engineered mice, there is a lack of reliable platforms to study quiescence of hematopoietic stem cells (HSCs). Here, we established a non-viral genome editing method optimized for mouse HSCs based on the CRISPR-Cas9 system and used it in combination with a culture condition that maintains quiescence. We demonstrated that edited HSCs can be reverted to quiescence using only physiological factors found in bone marrow. Edited HSCs in the quiescence-maintaining condition retained their phenotypes and functions better than those in the proliferative condition. By applying this approach, we confirmed that loss of glucose-6-phosphate isomerase 1 (Gpi1) or glyceraldehyde-3-phosphate dehydrogenase (Gapdh), which are glycolytic enzymes, severely impaired proliferative HSCs, but this effect was minimized in quiescent HSCs due to mitochondrial compensation. Our results show that an HSC-optimized genome editing method in combination with quiescence-maintaining culture will help to analyze quiescence of HSCs ex vivo.</STUDY_ABSTRACT>
            <CENTER_PROJECT_NAME>Reversion to quiescence preserves hematopoietic stem cells following genome editing</CENTER_PROJECT_NAME>
            <RELATED_STUDIES>
                <RELATED_STUDY>
                    <RELATED_LINK>
                        <DB>bioproject</DB>
                        <ID>PRJDB12362</ID>
                        <LABEL>PRJDB12362</LABEL>
                    </RELATED_LINK>
                    <IS_PRIMARY>true</IS_PRIMARY>
                </RELATED_STUDY>
            </RELATED_STUDIES>
            <STUDY_DESCRIPTION>Other than genetically engineered mice, there is a lack of reliable platforms to study quiescence of hematopoietic stem cells (HSCs). Here, we established a non-viral genome editing method optimized for mouse HSCs based on the CRISPR-Cas9 system and used it in combination with a culture condition that maintains quiescence. We demonstrated that edited HSCs can be reverted to quiescence using only physiological factors found in bone marrow. Edited HSCs in the quiescence-maintaining condition retained their phenotypes and functions better than those in the proliferative condition. By applying this approach, we confirmed that loss of glucose-6-phosphate isomerase 1 (Gpi1) or glyceraldehyde-3-phosphate dehydrogenase (Gapdh), which are glycolytic enzymes, severely impaired proliferative HSCs, but this effect was minimized in quiescent HSCs due to mitochondrial compensation. Our results show that an HSC-optimized genome editing method in combination with quiescence-maintaining culture will help to analyze quiescence of HSCs ex vivo.</STUDY_DESCRIPTION>
        </DESCRIPTOR>
    </STUDY>
</STUDY_SET>
